Publicacións en colaboración con investigadores/as de Clínica Universitaria de Navarra (36)

2024

  1. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  2. Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564

  3. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2021

  1. Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial

    ERJ Open Research, Vol. 7, Núm. 2, pp. 00773-2020

  2. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD

    Clinical Imaging, Vol. 78, pp. 136-141

2020

  1. Exploring the association between emphysema phenotypes and low bone mineral density in smokers with and without copd

    International Journal of COPD, Vol. 15, pp. 1823-1829

  2. Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy

    Radiologia, Vol. 62, Núm. 2, pp. 131-138

2019

  1. Prognostic Validation Using GesEPOC 2017 Severity Criteria

    Archivos de Bronconeumologia

  2. The effect of radiographic emphysema in assessing lung cancer risk

    Thorax, Vol. 74, Núm. 9, pp. 858-864

  3. Validación pronóstica según los criterios de la GesEPOC 2017

    Archivos de bronconeumologia, Vol. 55, Núm. 8, pp. 409-413

2018

  1. Comparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports impact on grouping and outcomes

    American Journal of Respiratory and Critical Care Medicine, Vol. 197, Núm. 4, pp. 463-469

  2. The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study

    Respirology, Vol. 23, Núm. 5, pp. 485-491

2017

  1. Erratum: Telomere shortening and accelerated aging in COPD: Findings from the BODE cohort [Respiratory Research. 59, 1, (2017)(18)] DOI: 10.1186/s12931-017-0547-4

    Respiratory Research

  2. Is Chronic Obstructive Pulmonary Disease Really a Progressive Disease?

    Archivos de Bronconeumologia, Vol. 53, Núm. 7, pp. 362-363

  3. Lung Cancer and Emphysema

    Archivos de Bronconeumologia, Vol. 53, Núm. 2, pp. 47-48

  4. Telomere shortening and accelerated aging in COPD: Findings from the BODE cohort

    Respiratory Research, Vol. 18, Núm. 1

2016

  1. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: A pilot study

    International Journal of COPD, Vol. 11, Núm. 1, pp. 1217-1222

  2. Impact of surgery for stage IA non-smallcell lung cancer on patient quality of life

    Journal of Community and Supportive Oncology, Vol. 14, Núm. 1, pp. 37-44

2015

  1. BODE Index: A Good Quality of Life Marker in Chronic Obstructive Pulmonary Disease Patients

    Archivos de Bronconeumologia, Vol. 51, Núm. 7, pp. 311-312